Clinical Implications of Serum NT-pro Brain Natriuretic Peptides in Type1 Diabetes with Positive Antiviral Antibodies

Авторы

  • Marwan Al-Nimer Professor of PharmacologyCollege of Medicine, Baghdad, Iraq
  • Zhian Mahmood Ibrahim Dezayee Senior Lecturer in Immunity, Hawler Medical University, Erbil,
  • Ismail I. Latif Assistant Professor in Microbiology, College of Medicine, Diyala University, Diyala
  • Ahood K. Ibrahim Director of Clinical Biochemistry Laboratory at Ibn Al-Bitar Specialized Center for Cardiac Surgery, Baghdad

Ключевые слова:

Type 1 diabetes, NT-proBNP, antiviral antibody

Аннотация

 Subclinical cardiovascular disease is common in diabetes mellitus and is associated with an increased risk of cardiovascular events including heart failure. This study was aimed to assess the association of NT-proBNP as a marker of heart failure and antiviral antibodies in patients with type 1 diabetes mellitus (T1D). One hundred and forty-seven T1D patients (65 male and 82 female) and 24 (11 male and 13 female) non-diabetic control subjects were admitted in the study. Fasting venous blood samples were obtained from patients and the sera were separated for determination of NT-proBNP, IgG antibody against rubella, cytomegalovirus, and coxsacki virus. Serum NT-proBNP was determined using the technique of Enzyme Linked Fluorescent Assay (ELFA) and ELISA-based determination of serum IgG antibody (I.U./mL) against rubella virus and cytomegalovirus coxsacki virus. Seventy-two patients expressed positive antiviral antibody titer; anti-rubella IgG (24), anti-cytomegalovirus IgG (18) and anti-Coxsackie IgG (36). Serum level of NT-proBNP higher than 300 pg /mL reported in 14 patients (9.5%) indicated mild-severe heart failure. Significant association between the positive anti-rubella IgG and higher level of serum NT-proBNP (odd ratio 2.013) and significant correlation (r = 0.555) between the serum level of NT-proBNP and anti-cytomegalovirus IgG were observed. It is concluded that serum NT-proBNP is significantly increased in T1D patients with positive antiviral antibodies in absence of clinical symptoms related to heart failure.  

Загрузки

Опубликован

2013-05-27

Выпуск

Том 3 № 1 (2013)

Раздел

Research Articles

Лицензия

Declaration and Copyright Transfer Form

(to be completed by authors)

I/ We, the undersigned author(s) of the submitted manuscript, hereby declare, that the above manuscript which is submitted for publication in the STM Journals(s), is not published already in part or whole (except in the form of abstract) in any journal or magazine for private or public circulation, and, is not under consideration of publication elsewhere.

·         I/We will not withdraw the manuscript after 1 week of submission as I have read the Author Guidelines and will adhere to the guidelines.

·         I/We Author(s ) have niether given nor will give this manuscript elsewhere for publishing after submitting in STM Journal(s).

·         I/ We have read the original version of the manuscript and am/ are responsible for the thought contents embodied in it. The work dealt in the manuscript is my/ our own, and my/ our individual contribution to this work is significant enough to qualify for authorship.

·          I/We also agree to the authorship of the article in the following order:

Author’s name                                    

 

1. ________________

2. ________________

3. ________________

_______________

We  Author(s) tick this box and would request you to consider it as our signature as we agree to the terms of this Copyright Notice, which will apply to this submission if and when it is published by this journal.